Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
no relationship Processed

Abbott Laboratories & Astec LifeSciences

6 shared events · Importance 3 · Last updated Mar 31, 2026

Importance
3
Shared Events
6
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard

Abbott Laboratories and Astec LifeSciences do not have a direct business-to-business relationship. Abbott focuses on diagnostics, medical devices, nutritionals, and branded generic medicines, while Astec LifeSciences manufactures agrochemicals and pharmaceutical intermediates.

30
Business
Abbott Laboratories: Dr. Reddy's is another Indian competitor developing a Keytruda biosimilar with Alvogen, targeting the same US market.
Astec LifeSciences: Zydus is a competitor developing its own Keytruda biosimilar (FYB206) with Formycon AG, facing similar market opportunities.
Sep 03, 2026 · 6 articles
15
Regulatory
Abbott Laboratories: Indian pharmaceutical company marketing a Pertuzumab biosimilar alternative domestically, part of the competitive landscape noted in the articles.
Astec LifeSciences: One of several Indian domestic players marketing a Pertuzumab biosimilar alternative in India, facing increased competition from Biocon's European expansion.
Sep 21, 2026 · 7 articles
10
Business
Abbott Laboratories: As a competitor in biosimilars, Alkem may face increased competition in Brazil's public market.
Astec LifeSciences: As a competitor in biosimilars, Zydus may face increased competition in Brazil's public market.
Sep 08, 2026 · 6 articles
0
Business
Astec LifeSciences: Astec LifeSciences is among the Indian pharmaceutical companies that have introduced generic semaglutide brands, contributing to the market shift.
Mar 30, 2026 · 8 articles
0
Business
Mar 20, 2026 · 8 articles
0
Business
Mar 17, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Abbott Laboratories and Astec LifeSciences interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.